logo
episode-header-image
Oct 2024
23m 58s

Hot shot: the wider promise of weight-lo...

The Economist
About this episode

First they treated diabetes. Then obesity. Now GLP-1 drugs are being tested on a range of other diseases too. Though the US economy is roaring, many Americans are glum about its prospects. How could that affect the election (9:02)? And our podcast on why Chinese migrants are making perilous journeys through the jungle to reach America (16:55).


Listen to what matters most, from global politics and business to science and technology—Subscribe to Economist Podcasts+


For more information about how to access Economist Podcasts+, please visit our FAQs page or watch our video explaining how to link your account. 



Up next
Yesterday
Liberté, égalité, désordre: chaos in France
France’s newly-appointed prime minister has resigned only weeks into the job. Now President Emmanual Macron has given him 48 hours to come up with a plan for next year’s budget. Can Macron survive the turmoil? As driverless taxis take over San Francisco, what will happen to the h ... Show More
21m 3s
Oct 7
Man of steel, and aluminium: Carney talks trade with Trump
The swiftest way for Prime Minister Mark Carney to ease pressure on Canada’s economy is to convince President Donald Trump today to pare back tariffs. But he has far broader plans afoot, too. A heady online mix of e-commerce and entertainment is creating a new generation of shopp ... Show More
21m 58s
Oct 6
One peace at a time: hopeful Gaza talks
As negotiators gather in Egypt, appetite for a short-term peace seems high on all sides. But there is much ambiguity surrounding a lasting accord. In New York, renters fear being evicted far less than they once did—but pity flat-hunters. And remembering Kim Seong Min, a North Kor ... Show More
22m 54s
Recommended Episodes
Aug 2024
The chips are down: will diet drugs devour junk food?
Snack-food companies have long shown their adaptability to changing diets. How could the rise of appetite-suppressing drugs and fears about ultra-processed foods change the food we consume? How hearing aids and other lifestyle choices can reduce your risk of dementia (11:00). And ... Show More
22m 30s
Sep 16
Honey, we shrunk the kids: population fall
Falling fertility makes a global decline in population inevitable. That will change the shape and make up of societies. But it may not make us poorer. Are large language models really woke? And reading is on the wane – and why that matters. Listen to what matters most, from globa ... Show More
23m 46s
Sep 2
Call the shots: vaccine cuts imperil global health
America’s health secretary, RFK Jr, is known for his opposition to vaccines, particularly mRNA jabs, that have the potential to treat a large swathe of diseases. Slashing funding will have long term implications beyond America. Our correspondent visits Britain’s biggest and newes ... Show More
21m 26s
Apr 2024
Money Talks: Why weight-loss drugs will reshape the world
More than 1bn people around the world are obese. That means there should be extraordinary demand for drugs to cure or mitigate the condition. Novo Nordisk is now Europe’s most valuable company and Eli Lilly’s market value has more than doubled. Both make the “miracle” drugs that ... Show More
36m 59s
Feb 2025
Chinese Biotech Is Having A DeepSeek Moment
P.M. Edition for Feb. 7. China’s biotech industry is creating new drugs more cheaply and quickly than its U.S. counterparts. WSJ Heard on the Street columnist David Wainer tells us what’s behind the sector’s rise. Plus, new data show the U.S. economy added fewer jobs than expecte ... Show More
13m 48s
Sep 25
Home truths: Ukraine’s internal strains
A snapshot of the country reveals deepening military and economic problems—and, perhaps above all, political ones. America’s efforts to clamp down on skilled-worker visas will have far-reaching unintended consequences. And globally, more children today are obese than underweight. ... Show More
21m 15s
Sep 18
Wary pharma: AstraZeneca sours on UK
Pharmaceutical giant AstraZeneca has paused a £200m investment in Britain and could move its primary listing to America. Can the UK maintain its status as a “life-science superpower”? Why autonomous air wings are the future of war in the sky. And how scientists in the Caribbean a ... Show More
22m 31s
Sep 29
Fortunes of war: is Russia’s economy slowing?
The collapse of Russia’s wartime economy has long been foretold, yet massive fiscal stimulus has compensated for the effect of sanctions. Though the pinch is now being felt, the labour market is surprisingly resilient. Protesters in China are getting more creative. And why car to ... Show More
23m 30s
Jan 2025
Putty people: can Trump get his picks?
As some of Donald Trump’s most controversial choices for top jobs are questioned this week, our correspondent analyses how supine Republicans may be in his second term. Has the luxury business passed its peak (09:57)? And why scientists are finding new ways to deal with an invasi ... Show More
23m 20s
Sep 1
Indonesia ablaze: Riots test Prabowo
For the past week in Indonesia, protesters have taken to the streets and cities have burned. President Prabowo is still popular – now he faces a big test. Climate change threatens the collapse of an Atlantic current that helps make Europe habitable. And facekinis become a fashion ... Show More
22m 42s